MGI Asia Pacific Pandemic Preparedness Program (PPP)
Empowering pathogen surveillance across the region
The MGI Asia Pacific (APAC) Pandemic Preparedness Program (PPP) is designed to equip institutions and laboratories across the Asia Pacific region, with plans for global expansion, with advanced pathogen surveillance and response solutions.
Born out of collaborations with key stakeholders, including the Asia Pathogen Genomics Initiative (APGI), the program delivers sustainable and impactful solutions for acute infectious disease surveillance. It focuses on delivering application-driven workflows that address pathogen genomics in an equitable, effective, and validated manner.
Exclusive Savings
Special discounts on selected sequencing instruments, consumables, and application packages for eligible organizations, ensuring cost-efficiency.
Order Freely
No minimum order requirements, with flexible purchasing terms to suit labs of all sizes — scale up or down as needed.
Ready-to-Run Kits
Preconfigured application bundles covering library preparation, sequencing, and data analysis, designed for infectious disease genomic surveillance.
Who can apply?
This program is tailored for universities, government institutes, hospitals, and research institutions that are focused on pathogen genomic surveillance. By providing access to tailored solutions, it ensures institutions can achieve timely, accurate, and actionable genomic insights.
The collaboration with APGI and its country partners marks a crucial step in expanding the reach of pathogen genomics. The program will soon extend to other institutions looking to develop or enhance their surveillance capabilities.
PPP application bundles
MGI offers transparent and cost-effective pricing on reagents and sequencing instruments through specialized pandemic preparedness application bundles. These bundles include all necessary reagents, consumables, and equipment for a full sample-to-answer workflow.
Eligible PPP recipients can access the following preconfigured Application Bundles (see table below) designed for various genomic surveillance needs. These bundles combine discounted rates on library preparation, sequencing, and analysis, with extraction costs included, according to product validation protocols.
| Category | Application | MGI Product Package | Usage |
|---|---|---|---|
| Shotgun Metagenomic Sequencing (mNGS) | Metagenomics Genomic Surveillance | Human Microbiome Metagenomics Sequencing Package | In-depth profiling and novel pathogen detection across the entire genetic repertoire of organisms for unknown/uncharacterized community samples. |
| Vector Species and Pathogen Identification | Vector and Microorganism Identification Package | Identification of vector species and/or pathogens they carry using primary samples, such as degraded and/or immature vector samples from extracted DNA and/or RNA. | |
| Whole Genome Sequencing (WGS) | Epidemiology Investigation for Mycobacterium Tuberculosis (MTB) Drug Resistance | MTB Whole Genome Sequencing Package | Whole genome sequencing of DNA extracted from Mycobacterium tuberculosis cultured isolates and Drug-resistance prediction based on the WHO MTB mutation catalogue, as well as MTBC & NTM identification, spoligotype identification and evolutionary analysis. |
| Targeted Sequencing (tNGS) | Rapid Identification of Mycobacterium Tuberculosis (MTB) Drug Resistance | ATOPlex MTB Sequencing Package | Detection of Mycobacterium tuberculosis complex or cultured samples targeted drug resistance genes, identification of mixed Non-tuberculous Mycobacteria (NTM) species, and drug resistance prediction based on the WHO MTB mutation catalogue for first- and second-line anti-tuberculosis drugs using extracted genomic DNA. |
| Human Immunodeficiency Virus (HIV-1) Drug Resistance | HIV-1 Drug Resistance Sequencing Products Package | Identification of HIV-1 virus genotype and targeted detection for drug resistance mutations in pol gene based on Stanford HIV Drug Resistance Database (HIVdb) and phylogenetic analysis using extracted total RNA from HIV-1 positive samples. | |
| SARS-CoV-2 Genomic Surveillance | SARS-CoV-2 Sequencing Package | Detection, clade identification, and phylogeny analysis of SARS-CoV-2 virus for single and mixed lineages using total RNA from wastewater, pharyngeal swabs, bronchoalveolar lavage fluid and other samples. | |
| Influenza A/B Genomic Surveillance | Respiratory Microbiome Genome Sequencing Package | Detection, assembly, subtype identification, and phylogenetic analysis of Influenza (A/B) virus using extracted total RNA from nasopharyngeal swabs. | |
| Monkeypox (MPXV) Genomic Surveillance | ATOPlex MPXV Sequencing Package | Detection, assembly, clade identification, and phylogenetic analysis of MPXV virus using extracted DNA from blister fluid or oropharyngeal swabs and nasal swabs. | |
| Dengue Virus (DENV1-4) Genomic Surveillance | ATOPlex DENV1-4 Sequencing Package | Detection, typing, clade identification and analysis of closely related genomes of DENV (1/2/3/4) using RNA extracted from plasma, serum and other samples. | |
| 16S rDNA Characterization | Microbiome Metabarcoding Sequencing Package | Metagenomic survey of species-level identification, composition, and community structures of bacteria based on 16S rDNA using genomic DNA extracted from complex microbiome samples. | |
| Pan-Pathogen and AMR Detection | Pan-Pathogen and Antimicrobial Resistance (AMR) Detection | Pan-Pathogen and Antimicrobial Resistance (AMR) Detection Package | Identification of 330 clinically relevant pathogens (bacteria, viruses, fungi, parasites) and 150 AMR genes using total nucleic acid extracted from various biospecimens. |
Note: Subject to hardware dependencies, software configurations, and application-specific optimized workflows. Additional analysis software may be required, with alternatives evaluated based on project urgency and scope.
How to apply
Interested in joining the MGI APAC PPP? Fill in your details below and submit a form. Our team will review your submission within 3–5 business days.
The personal information you provide will only be used for support, service, and technical purposes as detailed in our privacy policy.
*Program Availability: Currently, the PPP is available to countries in Southeast Asia (Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Myanmar, Cambodia, Laos, Brunei, Timor-Leste) and South Asia (India, Pakistan, Bangladesh, Sri Lanka, Nepal, Bhutan, Maldives).
